 - Patients must have previously untreated stage I or II NSCLC T11-2N0M0, T1-2N1M0, T3N0M0 and 1 of the following features: never smoker or 15 pack year smoking history andor bronchioloalveolar cancer either pure BAC, BAC with focal invasion or adenocarcinoma with BAC features 